These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 25989880)

  • 1. Impaired antioxidant HDL function is associated with premature myocardial infarction.
    Distelmaier K; Wiesbauer F; Blessberger H; Oravec S; Schrutka L; Binder C; Dostal E; Schillinger M; Wojta J; Lang IM; Maurer G; Huber K; Goliasch G
    Eur J Clin Invest; 2015 Jul; 45(7):731-8. PubMed ID: 25989880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative importance of different lipid risk factors for the development of myocardial infarction at a very young age (≤ 40 years of age).
    Goliasch G; Oravec S; Blessberger H; Dostal E; Hoke M; Wojta J; Schillinger M; Huber K; Maurer G; Wiesbauer F
    Eur J Clin Invest; 2012 Jun; 42(6):631-6. PubMed ID: 22150092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease.
    Patel PJ; Khera AV; Jafri K; Wilensky RL; Rader DJ
    J Am Coll Cardiol; 2011 Nov; 58(20):2068-75. PubMed ID: 22051328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of alkaline phosphatase with acute myocardial infarction in a population with high prevalence of hypovitaminosis D.
    Iqbal MP; Mehboobali N; Azam I; Tareen AK
    Clin Chim Acta; 2013 Oct; 425():192-5. PubMed ID: 23954837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive and Prognostic Value of High-density Lipoprotein Cholesterol in Young Male Patients with Acute Myocardial Infarction.
    Li Z; Huang J; Li N
    Chin Med J (Engl); 2017 5th Jan 2017; 130(1):77-82. PubMed ID: 28051027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction.
    Scaglione L; Bergerone S; Gambino R; Imazio M; Macchia G; Cravetto A; Gaschino G; Baralis G; Rosettani E; Pagano G; Cassader M
    Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):118-24. PubMed ID: 10464784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality.
    Silbernagel G; Schöttker B; Appelbaum S; Scharnagl H; Kleber ME; Grammer TB; Ritsch A; Mons U; Holleczek B; Goliasch G; Niessner A; Boehm BO; Schnabel RB; Brenner H; Blankenberg S; Landmesser U; März W
    Eur Heart J; 2013 Dec; 34(46):3563-71. PubMed ID: 24014391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test.
    Orbe J; Zudaire M; Serrano R; Coma-Canella I; Martínez de Sizarrondo S; Rodríguez JA; Páramo JA
    Thromb Haemost; 2008 Feb; 99(2):382-7. PubMed ID: 18278189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
    Sattler KJ; Herrmann J; Yün S; Lehmann N; Wang Z; Heusch G; Sack S; Erbel R; Levkau B
    Eur Heart J; 2009 Aug; 30(15):1894-902. PubMed ID: 19474052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
    Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
    Stampfer MJ; Sacks FM; Salvini S; Willett WC; Hennekens CH
    N Engl J Med; 1991 Aug; 325(6):373-81. PubMed ID: 2062328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Apr; 117(4):511-5. PubMed ID: 15109440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease.
    Sattler KJ; Elbasan S; Keul P; Elter-Schulz M; Bode C; Gräler MH; Bröcker-Preuss M; Budde T; Erbel R; Heusch G; Levkau B
    Basic Res Cardiol; 2010 Nov; 105(6):821-32. PubMed ID: 20652276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid profile and long-term outcome in premature myocardial infarction.
    Winter MP; Wiesbauer F; Blessberger H; Pavo N; Sulzgruber P; Huber K; Wojta J; Distelmaier K; Lang IM; Goliasch G
    Eur J Clin Invest; 2018 Oct; 48(10):e13008. PubMed ID: 30062727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-high density lipoprotein cholesterol is the best discriminator of myocardial infarction in young individuals.
    Rallidis LS; Pitsavos C; Panagiotakos DB; Sinos L; Stefanadis C; Kremastinos DT
    Atherosclerosis; 2005 Apr; 179(2):305-9. PubMed ID: 15777546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble galectin-3 is associated with premature myocardial infarction.
    Winter MP; Wiesbauer F; Alimohammadi A; Blessberger H; Pavo N; Schillinger M; Huber K; Wojta J; Lang IM; Maurer G; Goliasch G
    Eur J Clin Invest; 2016 May; 46(5):386-91. PubMed ID: 26880404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between periodontal disease and acute myocardial infarction.
    Emingil G; Buduneli E; Aliyev A; Akilli A; Atilla G
    J Periodontol; 2000 Dec; 71(12):1882-6. PubMed ID: 11156045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy.
    Patel PJ; Khera AV; Wilensky RL; Rader DJ
    Eur J Heart Fail; 2013 Nov; 15(11):1215-9. PubMed ID: 23709232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated low high density lipoprotein-cholesterol (HDL-C): implications of global risk reduction. Case report and systematic scientific review.
    Hayden MR; Tyagi SC
    Cardiovasc Diabetol; 2005 Jan; 4():1. PubMed ID: 15631632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.